Avalo Therapeutics, Inc. (AVTX)

CIK 1534120 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Avalo Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001810417-26-000021
Sep 1, 202640001918845-26-000031
Aug 19, 202640001810417-26-000019
Aug 19, 202640001918845-26-000029
Aug 18, 20261440001950047-26-008317
Aug 17, 20261440001950047-26-008220
Aug 17, 20261440001950047-26-008276
Aug 17, 20261440001950047-26-008273
Aug 14, 2026SCHEDULE 13G/A0000902664-26-003460
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097285
Aug 14, 2026SCHEDULE 13G/A0000921895-26-002164
Aug 14, 2026SCHEDULE 13G/A0001727492-26-000021
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000918
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003475
Aug 14, 2026SCHEDULE 13G/A0001897612-26-000606
Aug 13, 2026SCHEDULE 13G/A0001011438-26-000509
Aug 12, 202640002047607-26-000008
Aug 12, 202640001918845-26-000026
Aug 11, 20261440001950047-26-007948
Aug 10, 20261440001950047-26-007908
Aug 7, 2026SCHEDULE 13G0000093751-26-000415
Aug 7, 2026SCHEDULE 13G/A0000315066-26-002249
Aug 6, 20268-K0001534120-26-000048
Aug 6, 202610-Q0001534120-26-000049
Aug 6, 2026SCHEDULE 13G/A0000315066-26-001940